V11294A [162278-10-6]

TargetMol Chemicals

V11294A [162278-10-6]

72

Chemical

Research Use Only

V11294A

C23H31N5O2

409.52

V11294A is a novel PDE4 inhibitor. A single oral 300 mg dose of V11294A administered to healthy volunteers results in plasma concentrations adequate to inhibit activation of inflammatory cells ex vivo, which persists for at least 24 h without any adverse reactions

3 years

C(N1C=2C(=C(NCC)N=C1)N=C(C(C)C)N2)C3=CC(OC4CCCC4)=C(OC)C=C3

-20°C

12352200